Synapse - September 2019

This month on Synapse

IP, divestments, fragmentation and the future: M&A in life science

Emma Danks discusses the latest M&A trends in life sciences against a changing economic and technological background, and an uncertain political future.

Biosimilars – Clearing the way for launch

In the third session of our webinar series, our experts discuss strategies for clearing the way to an early launch of a biosimilar.

First Dutch GDPR fine for failing to ensure security of patient files

Marthe Riewald and Judith Krens report the first fine issued to a hospital in the Netherlands under the GDPR.

Dr Bill Frankland: Penicillin, the pollen count and perspectives on medicine

Cheng Bray interviews Dr Bill Frankland, pioneering allergist, on a remarkable life spanning the loss of the Titanic and leaving the EU.

Patents diary: September 2019

We present highlights of the month's patents and SPC cases and developments.